Publikationen in Zusammenarbeit mit Forschern von University of Tartu (52)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  2. Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis

    Clinical Epigenetics, Vol. 16, Núm. 1

2023

  1. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Explainable AI for the metaverse: A Short Survey

    2023 INTERNATIONAL CONFERENCE ON INTELLIGENT METAVERSE TECHNOLOGIES & APPLICATIONS, IMETA

  5. Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

    International Journal of Bipolar Disorders, Vol. 11, Núm. 1

  6. Federated Learning for the Metaverse: A Short Survey

    2023 INTERNATIONAL CONFERENCE ON INTELLIGENT METAVERSE TECHNOLOGIES & APPLICATIONS, IMETA

  7. Residential greenspace and lung function decline over 20 years in a prospective cohort: The ECRHS study

    Environment International, Vol. 178

2022

  1. Association between polarity of first episode and solar insolation in bipolar I disorder

    Journal of Psychosomatic Research, Vol. 160

  2. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study

    Pediatric Blood and Cancer, Vol. 69, Núm. 6

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

  5. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

    Journal of Headache and Pain, Vol. 22, Núm. 1

  3. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  6. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1